A detailed history of First Horizon Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 3,322 shares of NVO stock, worth $472,953. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,322
Previous 3,664 9.33%
Holding current value
$472,953
Previous $379,000 12.4%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 26, 2024

SELL
$102.11 - $135.92 $34,921 - $46,484
-342 Reduced 9.33%
3,322 $426,000
Q4 2023

Feb 06, 2024

SELL
$87.78 - $105.45 $23,788 - $28,576
-271 Reduced 6.89%
3,664 $379,000
Q3 2023

Oct 27, 2023

BUY
$90.94 - $199.54 $181,243 - $397,683
1,993 Added 102.63%
3,935 $357,000
Q2 2023

Aug 03, 2023

BUY
$155.98 - $172.65 $311 - $345
2 Added 0.1%
1,942 $314,000
Q1 2023

May 15, 2023

SELL
$132.34 - $159.14 $46,848 - $56,335
-354 Reduced 15.43%
1,940 $308,000
Q4 2022

Feb 10, 2023

SELL
$102.55 - $135.33 $20,920 - $27,607
-204 Reduced 8.17%
2,294 $310,000
Q3 2022

Nov 09, 2022

SELL
$95.28 - $116.93 $48,497 - $59,517
-509 Reduced 16.93%
2,498 $248,000
Q2 2022

Aug 02, 2022

BUY
$103.24 - $121.81 $264,500 - $312,077
2,562 Added 575.73%
3,007 $335,000
Q1 2022

May 10, 2022

SELL
$93.1 - $112.54 $122,519 - $148,102
-1,316 Reduced 74.73%
445 $49,000
Q4 2021

Feb 09, 2022

SELL
$95.88 - $117.08 $6,903 - $8,429
-72 Reduced 3.93%
1,761 $197,000
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $63,737 - $80,498
755 Added 70.04%
1,833 $175,000
Q3 2021

Nov 09, 2021

SELL
$84.42 - $106.62 $73,107 - $92,332
-866 Reduced 44.55%
1,078 $103,000
Q2 2021

Aug 09, 2021

SELL
$67.66 - $84.76 $6,766 - $8,476
-100 Reduced 4.89%
1,944 $162,000
Q1 2021

May 11, 2021

SELL
$67.06 - $75.82 $5,767 - $6,520
-86 Reduced 4.04%
2,044 $137,000
Q4 2020

Feb 11, 2021

SELL
$63.89 - $73.8 $6,197 - $7,158
-97 Reduced 4.36%
2,130 $148,000
Q3 2020

Nov 12, 2020

SELL
$63.69 - $70.22 $18,024 - $19,872
-283 Reduced 11.27%
2,227 $154,000
Q2 2020

Jul 31, 2020

SELL
$58.54 - $67.94 $1,580 - $1,834
-27 Reduced 1.06%
2,510 $164,000
Q1 2020

May 05, 2020

SELL
$49.46 - $64.78 $5,836 - $7,644
-118 Reduced 4.44%
2,537 $152,000
Q4 2019

Jan 07, 2020

SELL
$49.86 - $58.26 $5,135 - $6,000
-103 Reduced 3.73%
2,655 $153,000
Q3 2019

Oct 23, 2019

SELL
$47.54 - $53.43 $90,753 - $101,997
-1,909 Reduced 40.9%
2,758 $142,000
Q2 2019

Aug 05, 2019

SELL
$46.79 - $52.47 $42,953 - $48,167
-918 Reduced 16.44%
4,667 $0
Q1 2019

Apr 26, 2019

SELL
$46.36 - $52.63 $32,452 - $36,841
-700 Reduced 11.14%
5,585 $0
Q4 2018

Feb 11, 2019

BUY
$41.54 - $47.25 $47,023 - $53,487
1,132 Added 21.97%
6,285 $289,000
Q3 2018

Nov 05, 2018

SELL
$46.76 - $51.24 $91,836 - $100,635
-1,964 Reduced 27.6%
5,153 $0
Q2 2018

Aug 07, 2018

BUY
$44.29 - $50.42 $16,608 - $18,907
375 Added 5.56%
7,117 $0
Q1 2018

May 02, 2018

SELL
$48.49 - $58.14 $19,880 - $23,837
-410 Reduced 5.73%
6,742 $0
Q4 2017

Jan 25, 2018

SELL
$47.53 - $53.73 $38,261 - $43,252
-805 Reduced 10.12%
7,152 $0
Q3 2017

Nov 09, 2017

SELL
$41.15 - $49.22 $7,448 - $8,908
-181 Reduced 2.22%
7,957 $0
Q2 2017

Aug 14, 2017

BUY
N/A
8,138
8,138 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $321B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.